Showing 1 - 2 results of 2 for search 'David R Newell', query time: 0.01s Refine Results
  1. 1
    The enhanced in vivo activity of the combination of a MEK and a PI3K inhibitor correlates with [18F]-FLT PET in human colorectal cancer xenograft tumour-bearing mice.

    The enhanced in vivo activity of the combination of a MEK and a PI3K inhibitor correlates with [18F]-FLT PET in human colorectal cancer xenograft tumour-bearing mice. by Emma J Haagensen, Huw D Thomas, Ian Wilson, Suzannah J Harnor, Sara L Payne, Tommy Rennison, Kate M Smith, Ross J Maxwell, David R Newell

    Published 2013-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Characterisation of a Tip60 specific inhibitor, NU9056, in prostate cancer.

    Characterisation of a Tip60 specific inhibitor, NU9056, in prostate cancer. by Kelly Coffey, Timothy J Blackburn, Susan Cook, Bernard T Golding, Roger J Griffin, Ian R Hardcastle, Lorraine Hewitt, Kety Huberman, Hesta V McNeill, David R Newell, Celine Roche, Claudia A Ryan-Munden, Anna Watson, Craig N Robson

    Published 2012-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: